Biocompare.com RSS feed

02/08/2010 04:55 PM
GeoVax Labs, Inc. Begins Enrollment At Final Site For Preventative Vaccine; Next Step Is To Submit IND Application For Therapeutic Vaccine To FDA
GeoVax Labs, Inc. (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today provided an update on its vaccine trials progress.

02/08/2010 04:55 PM
Corgenix And Tulane Announce Award Of Additional NIH Contract To Expand Lassa Fever Research Towards Development Of Vaccines And Improved Therapeutic Agents
Corgenix Medical Corporation , a worldwide developer and marketer of diagnostic test kits, and Tulane University, today announced a major extension of the collaborative effort to combat viral hemorrhagic fever (VHF), an effort that will generate an additional $800,000 in contract revenue for Corgenix over the life of the contract.

02/08/2010 04:17 PM
Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response In Clinical Trial
Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today additional interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18 and is delivered via in vivo electroporation.

02/05/2010 06:56 PM
U.S. Adults Forgo Routine Immunization: Report
Tens of thousands of American adults die each year from pneumonia, influenza and other infectious diseases that could be prevented by routine vaccinations, according to a report released Thursday.

02/05/2010 04:15 PM
Breakthrough By Danish Scientists In Preventing Maternal Malaria
Researchers at the University of Copenhagen have become the first in the world to synthesize the entire protein that is responsible for life-threatening malaria in pregnant women and their unborn children. The protein known as VAR2CSA enables malaria parasites to accumulate in the placenta and can therefore potentially be used as the main component in a vaccine to trigger antibodies that protect pregnant women against malaria. The research team is now planning to test the efficacy of the protein-based vaccine on humans.

02/05/2010 01:05 PM
More Than 30 Percent Of Seniors Are Not Immunized Against Pneumonia In 36 States; New Report Finds Low Adult Vaccination Rates In U.S.
A new report, Adult Immunization: Shots to Save Lives, released today by the Trust for America's Health (TFAH), the Infectious Diseases Society of America (IDSA), and the Robert Wood Johnson Foundation (RWJF) found that more than 30 percent of adults ages 65 and older had not been immunized against pneumonia in 36 states as of 2008. The U.S. Centers for Disease Control and Prevention (CDC) and other experts recommend that all seniors should be vaccinated against pneumonia, which is a one-time shot for most individuals, since seniors who get the seasonal flu are at risk for developing pneumonia as a complication.

02/05/2010 12:26 PM
New Study Finds Possible Source Of Beta Cell Destruction That Leads To Type 1 Diabetes
Doctors at Eastern Virginia Medical School's Strelitz Diabetes Center have been stalking the culprit responsible for Type 1 diabetes. Now, they are one step closer.

02/05/2010 10:50 AM
New Vaccine Shows Promise Against Malaria In Early-Stage Study
A new vaccine tested in 100 West African children triggers the immune system to produce antibodies against the malaria parasite at levels normally seen only in adults who have strong resistance to the disease.

02/04/2010 06:05 AM
Test Could Predict Which Idiopathic Pulmonary Fibrosis Patients Will Become Severely Ill
A simple blood test could predict which patients with the lung-scarring disease known as idiopathic pulmonary fibrosis (IPF) are soon to get far worse, an indicator that could one day influence their treatment, according to researchers at the University of Pittsburgh School of Medicine. Their findings, published online last week in PLoS One, indicate that the body's immune cells attack healthy lung tissue, suggesting that IPF is in fact an immunologic disease.

02/04/2010 05:39 AM
NIH Scientists Identify Maternal and Fetal Genes That Increase Preterm Birth Risk
Researchers at the National Institutes of Health have identified DNA variants in mothers and fetuses that appear to increase the risk for preterm labor and delivery. The DNA variants were in genes involved in the regulation of inflammation and of the extracellular matrix, the mesh-like material that holds cells within tissues.